PP_1170x120_10-25-21

Rheumatrex Tablets

Aurobindo gets FDA nod for methotrexate tablets

Aurobindo gets FDA nod for methotrexate tablets

EAST WINDSOR, N.J. – Aurobindo has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application methotrexate tablets USP, 2.5 mg. Aurobindo’s methotrexate tablets USP, 2.5 mg are an AB-rated generic equivalent to the reference listed drug (RLD), Rheumatrex Tablets, 2.5 mg, of DAVA Pharmaceuticals. Methotrexate tablets are indicated for: